Study directory

Mental health studies with practical context.

Compare studies and check their requirements with the research team.

Back to overview

10661studies shown

Showing 9,289-9,300 of 10,661

Behavioral study icon

TerminatedNCT05329779

Study on Allopregnanolone and Depression in Perimenopausal Women

This summary needs review. Please check the official study record and contact the research team for details.

In United States

DepressionBehavioralFrom 40 Years to 60 Years

Countries: United States
Sponsor: Brigham and Women's Hospital
Condition: Depression

Behavioral study icon

CompletedNCT02840435

Study on Sit to Quit Phone Intervention

This summary needs review. Please check the official study record and contact the research team for details.

Remote / online

AddictionBehavioralOver 18 Years

Countries: United States
Sponsor: Duke University
Condition: Addiction

Other study type icon

TerminatedNCT02845687

Study on Smoking Cessation and Cost Outcomes in the Duke Smoking Cessation Program

This summary needs review. Please check the official study record and contact the research team for details.

In United States

AddictionObservationalOver 18 Years

Countries: United States
Sponsor: Duke University
Condition: Addiction

Drug study icon

CompletedNCT02670551

Study on the Efficacy, Safety, and Tolerability of Cariprazine Relative to Placebo in people with Bipolar I Depression

This study is completed in the United States, in Bulgaria, in Estonia, .... It focuses on depression.

In United States

Bipolarity, DepressionDrugFrom 18 Years to 65 Years

Countries: United States, Bulgaria, Estonia, ...
Sponsor: Forest Laboratories
Condition: Bipolarity, Depression

Behavioral study icon

TerminatedNCT02259634

Study on the Impact of Patient Navigators on the Health Education and Quality of Life in Formerly Incarcerated Patients

This study was terminated in the United States. It focuses on Addiction.

In United States

AddictionBehavioralOver 18 Years

Countries: United States
Sponsor: St. Luke's-Roosevelt Hospital Center
Condition: Addiction

Device study icon

CompletedNCT02158663

Study Testing if Fast or Slow rTMS is Better for PTSD (PTSD)

This summary needs review. Please check the official study record and contact the research team for details.

In United States

PTSD, DepressionDeviceFrom 18 Years to 50 Years

Countries: United States
Sponsor: James A. Haley Veterans Administration Hospital
Condition: PTSD, Depression

Drug study icon

TerminatedNCT00669903

Study to Asses Pharmacodynamics, Pharmacokinetics, Safety and Tolerability of AZD0328 in people with Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In United States

SchizophreniaDrugFrom 18 Years to 55 Years

Countries: United States
Sponsor: AstraZeneca
Condition: Schizophrenia

Other study type icon

CompletedNCT05956483

Accuracy of Rapid Mood Screener for depression

This study is completed in the United States. It is testing accuracy of Rapid Mood Screener for depression.

In United States

Bipolarity, DepressionObservationalOver 18 Years

Countries: United States
Sponsor: AbbVie
Condition: Bipolarity, Depression

Drug study icon

CompletedNCT02876900

HP3070 for schizophrenia

This study is completed in the United States. It is testing HP3070 for schizophrenia.

In United States

SchizophreniaDrugOver 18 Years

Countries: United States
Sponsor: Noven Pharmaceuticals, Inc.
Condition: Schizophrenia

Drug study icon

CompletedNCT04976855

Repeated Doses of INDV-2000 for Addiction

This study is completed in the United States. It is testing Repeated Doses of INDV-2000 for Addiction.

In United States

AddictionDrugFrom 18 Years to 65 Years

Countries: United States
Sponsor: Indivior Inc.
Condition: Addiction

Drug study icon

CompletedNCT06572449

Effectiveness of Slowly Increasing Dose and Food Effect of KarXT in schizophrenia

This study is completed in the United States. It is testing Slowly Increasing Dose and Food Effect of KarXT for schizophrenia.

In United States

SchizophreniaDrugFrom 18 Years to 65 Years

Countries: United States
Sponsor: Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Condition: Schizophrenia

Drug study icon

CompletedNCT00228540

Satisfaction With Modafinil Treatment for ADHD

This study is completed in the United States. It is testing satisfaction With Modafinil Treatment for ADHD.

In United States

ADHDDrugFrom 6 Years to 17 Years

Countries: United States
Sponsor: Cephalon
Condition: ADHD

Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.